Skip to content

HIV diagnosed later in Africans in south London

HIV causes metabolic disturbances in the absence of antiretroviral therapy

Starting HAART with a CD4 cell count below 100 cells/mm3 a risk factor for IRIS, study finds

Revisions to India’s patent law could affect future supply of affordable generic antiretrovirals

Argentinian generic indinavir compares well with Crixivan

TB drug discovery to receive major boost

Treatment for bone mineral loss: alendronate safe and effective in HIV

A quarter of US women stop HAART within five years

Protease inhibitors down-regulate oestrogen receptors in fat; possible contributor to fat loss?